The information provided on this page is for reference only. Please refer to the latest information published by the partner company.
StickyCell has developed and patented a pioneering blood testing system, ‘LAFA’ (leukocyte adhesive function assay), for analysing the human immune system and vulnerability to diseases.
Our immune system induces inflammation when circulating leukocytes are activated and become “stickier” on the blood vessel wall for translocation into surrounding tissues. The LAFA testing system assesses the leukocytes’ ability to cause inflammation, using microfluidic chips and microfluidic fluorescent image-capturing system to measure the leukocyte’s “stickiness” and the potential to cause inflammation, thus delivering unique scientific insights and machine-learning outcomes for early detection, prevention and personalised treatment of various human diseases.